Through our deep scientific understanding of the gut microbiome and nutrition during the earliest stages of life, we uncover bacterial strains foundational to human health.
The powerful single strain that matters for infants.
Our discovery of B. infantis EVC001—a bacterial strain thought to have disappeared from developed countries—proves to be the microbial partner nature intended. While B. infantis has evolved to uniquely pair with human milk, only EVC001 is clinically shown to have all the genes required to metabolize the human milk oligosaccharides (HMOs) in human milk.
Equally important, it contains the functional genes necessary to produce metabolites that positively support healthy immune system function when introduced during this short but critical time. By enabling the delivery of B. infantis EVC001 from birth, we maximize that small but crucial window of opportunity.
human milk and B. infantis EVC001.
Human milk feeds the baby—and B. infantis EVC001. Together, they create the system intended to nourish and help protect baby.
The Big Impact
Evidence shows EVC001, our strain of B. infantis, contains all the functional genes necessary to unlock the full power of human milk by transforming human milk oligosaccharides (HMOs) into organic molecules that human cells can absorb, providing more digestible nutrients for newborns.
The Big Difference
Without B. infantis EVC001, research published in mSphere and Frontiers in Pediatrics show these HMOs, unabsorbed, go into the stool.
The Right Signals
B. infantis EVC001 converts HMOs into key signaling molecules called metabolites.
For Better Health
Recent research published in Cell, shows these metabolites promote healthy gut function and help program immune cells to be tolerant instead of over reactive.
The Big Issue
Research published in Scientific Reports shows B. infantis is missing in more than 90% of infants born in the U.S. where high antibiotic use and modern feeding and birthing practices are prevalent.
The Health Concern
Countries like the US, with low prevalence of B. infantis, show higher incidences of atopic and autoimmune diseases. While evidence shows populations with higher prevalence of B. infantis have lower incidences for immune-mediated diseases.
Whether babies receive human milk or are mix-fed with formula, our current product portfolio supports babies along their feeding journey, starting with the first feed through their transition away from drinking human milk.
|A daily powder containing B. infantis EVC001, the bacterial strain shown to work with human milk to help establish a healthy gut microbiome, protect from potentially harmful bacteria, and help support immune function.|
|Ready-to-use, single serve liquid made specifically for NICU and Labor and Delivery use to help stabilize the infant gut against potential hospital acquired pathogens.|
Call us at (844) 463-8486 for customer service, support, and to learn more about our products.